Citi Starts Anthera Pharma (ANTH) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Wall St set for muted open as tech stocks take a breather
- Oil steadies on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Five things to watch in markets in the week ahead
- Citi sees room for further equities upside in 2027 on resilient earnings growth
Tweet
Share
E-mailGet Alerts ANTH Hot Sheet
Price: $0.00 --0%
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 24
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 24
Join SI Premium – FREE
Citi initiates coverage on Anthera Pharma (NASDAQ: ANTH) with a Buy. PT $11.00.
For more ratings news on Anthera Pharma click here and for the rating history of Anthera Pharma click here.
Shares of Anthera Pharma closed at $4.80 yesterday.
For more ratings news on Anthera Pharma click here and for the rating history of Anthera Pharma click here.
Shares of Anthera Pharma closed at $4.80 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Reinstates Hitachi Construction Machinery Co Ltd (6305:JP) (HTCMY) at Sell
- Leerink Assumes Zentalis Pharmaceuticals (ZNTL) at Outperform
- Citi upgrades Harley-Davidson to Buy with $33 price target
Create E-mail Alert Related Categories
New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
